Searched for
COVAXIN TRIAL
Covaxin trial data: Bharat Biotech vaccine shows 77.8% overall efficacy, 65% against Delta variant03 Jul, 2021, 11.01 AM IST- CM Yediyurappa launches phase-3 trials of Covaxin in Bengaluru02 Dec, 2020, 03.22 PM IST
- Bharat Biotech’s consent forms 'must' for Covaxin shot; What does the form say?16 Jan, 2021, 05.36 PM IST
- Bharat Biotech Covaxin Efficacy Data: How effective is the vaccine?04 Mar, 2021, 03.15 PM IST
- Covaxin trials in children between 2-18 years to begin in 10-12 Days: Govt19 May, 2021, 09.16 AM IST
- Bharat Biotech’s 'Covaxin' gets SEC nod for phase 2-3 clinical trials on 2 to 18 year-olds12 May, 2021, 02.31 PM IST
- COVID vaccine: 'Covaxin' trials begin for kids aged 12-18 in Nagpur06 Jun, 2021, 08.35 PM IST
- Covaxin triggers immune response, no adverse effects in phase 1 trial17 Dec, 2020, 09.13 AM IST
- Covid vaccination drive: Bharat Biotech to pay compensation if Covaxin causes side effects16 Jan, 2021, 03.55 PM IST
- Covaxin phase 3 trial data approved by subject expert committee, shows 77.8 % efficacy22 Jun, 2021, 03.30 PM IST
- COVID-19 Vaccine: Phase-3 trial of Covaxin begins at Sola Civil Hospital in Ahmedabad27 Nov, 2020, 09.34 PM IST
- Haryana health minister Anil Vij gets trial dose of Covid vaccine20 Nov, 2020, 05.20 PM IST
- Covid-19 vaccine: Expert Committee recommends trials on mixing Covaxin and Covishield30 Jul, 2021, 09.30 AM IST
- Drugs Controller General accepts expert committee report to allow Covaxin jabs without clinical trial11 Mar, 2021, 03.00 PM IST
- COVID Vaccine Trials: AIIMS gives a nod for human trial of Covaxin, received more than 1000 applications19 Jul, 2020, 08.21 PM IST
- DCGI allows Bharat Biotech to vaccinate children above 12 during clinical trial mode04 Jan, 2021, 12.08 PM IST
- COVID vaccine approval row: Bharat Biotech defends Covaxin after backlash over lack of data04 Jan, 2021, 06.51 PM IST
- COVID-19 vaccine: Covaxin has got approval for phase-III trials, says DG ICMR27 Oct, 2020, 08.26 PM IST
- Covaxin for kids: Bharat Biotech completes phase 2/3 trials of vaccine, to submit data to DCGI next week21 Sep, 2021, 03.04 PM IST
- Bharat Biotech’s 'Covaxin' gets DCGI nod for phase 2, 3 clinical trials on children aged 2 to 18 years13 May, 2021, 12.12 PM IST
Load More
